WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO

NEW YORK, June 1, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, announced today that Cavan M. Redmond has been appointed as its new Chief Executive Officer and as a member of its Board of Directors, effective May 31, 2012. Mr. Redmond, 51, joins WebMD from Pfizer Inc., the world's largest research-based pharmaceutical company, where he most recently served as Group President, Animal Health, Consumer Healthcare and Corporate Strategy and as a member of Pfizer's Executive Leadership Team. He was responsible for two diverse businesses while leading Pfizer's enterprise-wide Strategy, R&D Portfolio Management and Analysis, Global Commercial Operations and Continuous Improvement.

"Cavan brings unparalleled expertise and leadership in both biopharmaceutical and consumer healthcare to WebMD, and we are excited to welcome him to the WebMD team," said Martin J. Wygod, Chairman, WebMD. "He has a successful track record in identifying and leveraging new revenue opportunities, driving efficiency and establishing sustainable growth platforms. Along with our experienced management team, I have great confidence that Cavan will take WebMD to the next level. Cavan's proven ability to drive strategy and leverage the value of brands will be invaluable as WebMD continues to define and lead the market for digital health information."

Mr. Redmond has more than 20 years of healthcare experience encompassing a broad range of global healthcare businesses including biotechnology, pharmaceuticals, consumer healthcare and infant nutritionals. Mr. Redmond is a global healthcare strategist with a demonstrated ability to implement complex strategies in highly competitive and regulated markets. His strength in new product development, marketing, strategy and technology has resulted in a proven track record of building global brands, starting new businesses and reenergizing existing businesses. His biopharmaceutical experience also includes leading global strategic marketing, marketing research and analytics, new product marketing and multi-channel marketing programs. Prior to Pfizer's acquisition of Wyeth, Mr. Redmond served as the first Executive Vice President and General Manager of Wyeth's high-growth BioPharma Business Unit where he was responsible for the creation of the global biopharma business and grew the business significantly.

"WebMD is driving innovation in the rapidly changing healthcare market with its industry leading proprietary products and services for consumers, physicians and healthcare companies," said Mr. Redmond. "As the biopharmaceutical commercial model continues to evolve, WebMD can capitalize on these changes. WebMD's digital reach to consumers and physicians is an important part of the industry's communications infrastructure and as the healthcare industry undergoes significant changes, there is tremendous opportunity for WebMD to better enable patients and physicians to engage with one another. I look forward to working with WebMD's management team and employees, as well as the Board of Directors, to deliver innovation to our users and value for our customers and shareholders."

Mr. Redmond earned a Master of Administrative Science from The Johns Hopkins University, where he also completed a post-graduate fellowship in organizational change management; he also earned a Bachelor of Arts from the University of Maryland.

Anthony Vuolo, Chief Financial Officer, who has also served as interim Chief Executive Officer since January 2012 while the Board of Directors conducted a search for a permanent CEO, will continue in the position of Chief Financial Officer.

About WebMD
WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, emedicineHealth, RxList, theheart.org and Medscape Education.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements, including risks and uncertainties regarding: competition for advertisers and sponsors for our public portals and mobile platforms; changes in financial markets; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology industries. Further information about these matters can be found in our Securities and Exchange Commission filings. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

SOURCE WebMD Health Corp.